{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:16:13Z","timestamp":1787937373736,"version":"build-2784847793"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008967","name":"Philipps-Universit\u00e4t Marburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008967","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>New-onset refractory status epilepticus (NORSE) is a rare, life-threatening condition occurring in individuals without prior epilepsy or acute structural, toxic, or metabolic causes. Its etiology often remains cryptogenic, and inconsistent terminology hampers early recognition and treatment. This study aims to better characterize NORSE to support faster clinical diagnosis and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively identified all adult patients with status epilepticus (SE) admitted to the Department of Neurology, University Hospital Marburg, Germany, between 2011 and 2023. Demographic, etiologic, treatment, and outcome data from patients fulfilling consensus criteria for NORSE were compared with those of non-NORSE patients. We additionally performed a sensitivity analysis applying strict temporal diagnostic criteria (\u2264\u200972\u00a0h) to assess the impact of consensus-based classification on cohort definition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 779 patients with status epilepticus, 120 fulfilled criteria for NORSE, delineating a distinct clinical subgroup characterized by advanced age and a female predominance (67.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028). Phenotypically, NORSE was strongly associated with generalized seizure semiology (70.7%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and a higher burden of nonconvulsive status epilepticus (45.8%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), while the underlying etiology frequently remained cryptogenic (56.7%). This constellation translated into an adverse clinical trajectory, reflected by reduced rates of discharge home, increased in-hospital mortality (19.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and greater reliance on rehabilitative care. Notably, these differences were not paralleled by alterations in metabolic indices such as HbA1c or cholesterol, underscoring the limited discriminatory value of these parameters in NORSE. Application of strict temporal criteria resulted in a smaller, more conservative NORSE cohort, while key clinical features and outcomes remained largely unchanged.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>NORSE defines a distinct and severe clinical syndrome within status epilepticus, characterized by older age, female predominance and adverse outcomes. Beyond the clinical severity of NORSE, our findings show that cohort composition is highly sensitive to the temporal operationalization of consensus criteria. Standardized application of diagnostic timing may therefore be essential for comparability across NORSE studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42466-026-00526-z","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:17:06Z","timestamp":1787933826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes and unmet therapeutic needs in new-onset refractory status epilepticus: evidence from a retrospective cohort"],"prefix":"10.1186","volume":"8","author":[{"given":"Clara","family":"J\u00fcnemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Menche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Philipp","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Strehlau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota-Eleni","family":"Tsalouchidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joane","family":"Winkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole J.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Habermehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Menzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Knake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"1","key":"526_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.30476\/IJMS.2021.91645.2289","volume":"48","author":"A Amanlou","year":"2023","unstructured":"Amanlou, A., Nassireslami, E., Dehpour, A. R., Rashidian, A., & Chamanara, M. (2023). Beneficial Effects of Statins on Seizures Independent of Their Lipid-Lowering Effect: A Narrative Review. Iranian journal of medical sciences, 48(1), 13\u201325. https:\/\/doi.org\/10.30476\/IJMS.2021.91645.2289","journal-title":"Iranian journal of medical sciences"},{"key":"526_CR2","doi-asserted-by":"publisher","unstructured":"Cabrera Kang, C. M., Gaspard, N., LaRoche, S. M., & Foreman, B. (2017). Survey of the diagnostic and therapeutic approach to new-onset refractory status epilepticus. Seizure 46, 24\u201330. https:\/\/doi.org\/10.1016\/j.seizure.2017.02.003","DOI":"10.1016\/j.seizure.2017.02.003"},{"issue":"4","key":"526_CR3","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/epi.18267","volume":"66","author":"PH Espino","year":"2025","unstructured":"Espino, P. H., Eschbach, K., Blank, L. J., Cervenka, M. C., Muscal, E., Farias-Moeller, R., et al. (2025). New onset refractory status epilepticus: Long-term outcomes beyond seizures. Epilepsia, 66(4), 988\u20131005. https:\/\/doi.org\/10.1111\/epi.18267","journal-title":"Epilepsia"},{"issue":"1","key":"526_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42466-025-00431-x","volume":"7","author":"K Feil","year":"2025","unstructured":"Feil, K., L\u00fcthgens, D., Adolph, M., Kindzierski, S., Single, C., Becker, F., et al. (2025). Ketogenic diet for status epilepticus in adult intensive care unit patients: A standard operating procedure. Neurological research and practice, 7(1), 1\u201310. https:\/\/doi.org\/10.1186\/s42466-025-00431-x","journal-title":"Neurological research and practice"},{"issue":"1","key":"526_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","volume":"80","author":"EP Flanagan","year":"2023","unstructured":"Flanagan, E. P., Geschwind, M. D., Lopez-Chiriboga, A., Sebastian; Blackburn, K. M., Turaga, S., Binks, S., et al. (2023). Autoimmune Encephalitis Misdiagnosis in Adults. JAMA neurology, 80(1), 30\u201339. https:\/\/doi.org\/10.1001\/jamaneurol.2022.4251","journal-title":"JAMA neurology"},{"issue":"18","key":"526_CR6","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","volume":"85","author":"N Gaspard","year":"2015","unstructured":"Gaspard, N., Foreman, B. P., Alvarez, V., Cabrera Kang, C., Probasco, J. C., Jongeling, A. C., et al. (2015). New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology, 85(18), 1604\u20131613. https:\/\/doi.org\/10.1212\/WNL.0000000000001940","journal-title":"Neurology"},{"issue":"4","key":"526_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200403","volume":"12","author":"M Guillemaud","year":"2025","unstructured":"Guillemaud, M., Chavez, M., Kobeissy, F., Vezzani, A., Jimenez, A. D., Basha, M. M., et al. (2025). Identification of distinct biological groups of patients with cryptogenic NORSE via inflammatory profiling. Neurology, Neuroimmunology & Neuroinflammation, 12(4), Article e200403. https:\/\/doi.org\/10.1212\/NXI.0000000000200403","journal-title":"Neurology, Neuroimmunology & Neuroinflammation"},{"key":"526_CR8","doi-asserted-by":"publisher","first-page":"1523426","DOI":"10.3389\/fnut.2025.1523426","volume":"12","author":"HL Guo","year":"2025","unstructured":"Guo, H. L., Dong, N., Hu, Y. H., Qiu, J. C., Jiang, Z. Z., Liu, Q. Q., et al. (2025). Serum HDL-C levels in children with epilepsy: A single-center retrospective study. Frontiers in nutrition, 12, 1523426. https:\/\/doi.org\/10.3389\/fnut.2025.1523426","journal-title":"Frontiers in nutrition"},{"issue":"5","key":"526_CR9","doi-asserted-by":"publisher","first-page":"104406","DOI":"10.1016\/j.braindev.2025.104406","volume":"47","author":"A Hanin","year":"2025","unstructured":"Hanin, A., & Hirsch, L. J. (2025). Immune dysregulation in new-onset refractory status epilepticus (NORSE): Current insights and therapeutic perspectives. Brain & development, 47(5), 104406. https:\/\/doi.org\/10.1016\/j.braindev.2025.104406","journal-title":"Brain & development"},{"key":"526_CR10","doi-asserted-by":"publisher","first-page":"105346","DOI":"10.1016\/j.nbd.2021.105346","volume":"154","author":"A Hanin","year":"2021","unstructured":"Hanin, A., Baudin, P., Demeret, S., Roussel, D., Lecas, S., Teyssou, E., et al. (2021). Disturbances of brain cholesterol metabolism: A new excitotoxic process associated with status epilepticus. Neurobiology of disease, 154, 105346. https:\/\/doi.org\/10.1016\/j.nbd.2021.105346","journal-title":"Neurobiology of disease"},{"issue":"8","key":"526_CR11","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1111\/epi.18014","volume":"65","author":"A Hanin","year":"2024","unstructured":"Hanin, A., Jimenez, A. D., Gopaul, M., Asbell, H., Aydemir, S., Basha, M. M., et al. (2024). Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis. Epilepsia, 65(8), e148\u2013e155. https:\/\/doi.org\/10.1111\/epi.18014","journal-title":"Epilepsia"},{"key":"526_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/epi.70384","author":"S Hawksworth","year":"2026","unstructured":"Hawksworth, S., Moutonnet, N., Scott, G., Rajakulendran, S., Yogarajah, M., Walker, M. C., & Vivekananda, U. (2026). New onset refractory status epilepticus (NORSE) versus refractory status epilepticus not meeting NORSE criteria: A comparative clinical and electroencephalography-based study. Epilepsia. https:\/\/doi.org\/10.1002\/epi.70384","journal-title":"Epilepsia"},{"issue":"4","key":"526_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/epi.14016","volume":"59","author":"LJ Hirsch","year":"2018","unstructured":"Hirsch, L. J., Gaspard, N., van Baalen, A., Nabbout, R., Demeret, S., Loddenkemper, T., et al. (2018). Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia, 59(4), 739\u2013744. https:\/\/doi.org\/10.1111\/epi.14016","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"526_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/epi.14495","volume":"59","author":"C Kellinghaus","year":"2018","unstructured":"Kellinghaus, C., Rossetti, A. O., Trinka, E., Lang, N., Unterberger, I., R\u00fcegg, S., et al. (2018). SENSE registry for status epilepticus. Epilepsia, 59(Suppl 2), 150\u2013154. https:\/\/doi.org\/10.1111\/epi.14495","journal-title":"Epilepsia"},{"issue":"6","key":"526_CR15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1046\/j.1528-1157.2001.01101.x","volume":"42","author":"S Knake","year":"2001","unstructured":"Knake, S., Rosenow, F., Vescovi, M., Oertel, W. H., Mueller, H. H., Wirbatz, A., et al. (2001). Incidence of status epilepticus in adults in Germany: A prospective, population-based study. Epilepsia, 42(6), 714\u2013718. https:\/\/doi.org\/10.1046\/j.1528-1157.2001.01101.x","journal-title":"Epilepsia"},{"key":"526_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/epi.18535","author":"M Menche","year":"2025","unstructured":"Menche, M., J\u00fcnemann, C., Reese, J.-P., J\u00fcnemann, M., Teepker, M., Best, C., et al. (2025). The impact of revised definitions on the epidemiology of status epilepticus: A population-based study. Epilepsia. https:\/\/doi.org\/10.1111\/epi.18535","journal-title":"Epilepsia"},{"key":"526_CR17","doi-asserted-by":"publisher","first-page":"1134827","DOI":"10.3389\/fneur.2023.1134827","volume":"14","author":"R Nabbout","year":"2023","unstructured":"Nabbout, R., Matricardi, S., Liso, P., Dulac, O., & Oualha, M. (2023). Ketogenic diet for super-refractory status epilepticus (SRSE) with NORSE and FIRES: Single tertiary center experience and literature data. Frontiers in neurology, 14, 1134827. https:\/\/doi.org\/10.3389\/fneur.2023.1134827","journal-title":"Frontiers in neurology"},{"issue":"2","key":"526_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/WCO.0000000000001137","volume":"36","author":"C Sculier","year":"2023","unstructured":"Sculier, C., & Gaspard, N. (2023). New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Current opinion in neurology, 36(2), 110\u2013116. https:\/\/doi.org\/10.1097\/WCO.0000000000001137","journal-title":"Current opinion in neurology"},{"key":"526_CR19","doi-asserted-by":"publisher","unstructured":"Sculier, C., Barcia Aguilar, C., Gaspard, N., Ga\u00ednza-Lein, M. (2021). S\u00e1nchez Fern\u00e1ndez, Iv\u00e1n; Amengual-Gual, Marta. : Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort). In: Epilepsia 62 (7), S. 1629\u20131642. https:\/\/doi.org\/10.1111\/epi.16950","DOI":"10.1111\/epi.16950"},{"issue":"2","key":"526_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/ene.12428","volume":"22","author":"A Sierra-Marcos","year":"2015","unstructured":"Sierra-Marcos, A., Alvarez, V., Faouzi, M., Burnand, B., & Rossetti, A. O. (2015). Statins are associated with decreased mortality risk after status epilepticus. European journal of neurology, 22(2), 402\u2013405. https:\/\/doi.org\/10.1111\/ene.12428","journal-title":"European journal of neurology"},{"issue":"1","key":"526_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13054-024-04858-7","volume":"28","author":"F Stretti","year":"2024","unstructured":"Stretti, F., B\u00f6gli, S. Y., Casagrande, F., Eisele, A., Galovic, M., Keller, E., & Brandi, G. (2024). Long-term outcome in new onset refractory status epilepticus: A retrospective study. Critical care (London England), 28(1), 72. https:\/\/doi.org\/10.1186\/s13054-024-04858-7","journal-title":"Critical care (London England)"},{"issue":"1","key":"526_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/ene.12531","volume":"22","author":"R Sutter","year":"2015","unstructured":"Sutter, R., Kaplan, P. W., Marsch, S., Hammel, E. M., R\u00fcegg, S., & Ziai, W. C. (2015). Early predictors of refractory status epilepticus: An international two-center study. European journal of neurology, 22(1), 79\u201385. https:\/\/doi.org\/10.1111\/ene.12531","journal-title":"European journal of neurology"},{"issue":"6","key":"526_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/1060028018756650","volume":"52","author":"LU Trivedi","year":"2018","unstructured":"Trivedi, L. U., Alvarez, C. A., & Mansi, I. A. (2018). Association of Statin Therapy With Risk of Epilepsy in 2 Propensity Score-Matched Cohorts. The Annals of pharmacotherapy, 52(6), 546\u2013553. https:\/\/doi.org\/10.1177\/1060028018756650","journal-title":"The Annals of pharmacotherapy"},{"issue":"11","key":"526_CR24","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1111\/epi.17397","volume":"63","author":"R Wickstrom","year":"2022","unstructured":"Wickstrom, R., Taraschenko, O., Dilena, R., Payne, E. T., Specchio, N., Nabbout, R., et al. (2022). International consensus recommendations for management of New Onset Refractory Status Epilepticus (NORSE) incl. Febrile Infection-Related Epilepsy Syndrome (FIRES): Statements and Supporting Evidence. Epilepsia, 63(11), 2840\u20132864. https:\/\/doi.org\/10.1111\/epi.17397","journal-title":"Epilepsia"},{"issue":"1","key":"526_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42466-025-00435-7","volume":"7","author":"L Willems","year":"2025","unstructured":"Willems, L., Beuchat, I., Fisch, U., Sutter, R., Kellinghaus, C., & Strzelczyk, A. (2025). Diagnosis, treatment, and outcome prediction of non-convulsive status epilepticus in unconscious patients in intensive care units. Neurological research and practice, 7(1), 1\u201315. https:\/\/doi.org\/10.1186\/s42466-025-00435-7","journal-title":"Neurological research and practice"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-026-00526-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:17:07Z","timestamp":1787933827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42466-026-00526-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1186\/s42466-026-00526-z","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee in Marburg (reference number 24\u2013161 RS) and conducted in accordance with the Declaration of Helsinki. Due to the retrospective design of the study, informed consent was waived by the local ethics committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"71"}}